ImmunoGen touts 'home run' as ovarian cancer drug Elahere extends lives in landmark trial win
Fierce Pharma
MAY 3, 2023
ImmunoGen touts 'home run' as ovarian cancer drug Elahere extends lives in landmark trial win aliu Wed, 05/03/2023 - 14:50
Fierce Pharma
MAY 3, 2023
ImmunoGen touts 'home run' as ovarian cancer drug Elahere extends lives in landmark trial win aliu Wed, 05/03/2023 - 14:50
MedCity News
MAY 3, 2023
The Drug Enforcement Administration received 38,000 comments on its proposed rule that would roll back Covid-19 flexibilities for the prescribing of controlled substances via telemedicine. In response, the DEA chose to temporarily extend the flexibilities, a decision telehealth companies like Bicycle Health and Mindbloom are in support of.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Fierce Pharma
MAY 3, 2023
EU countries lay out framework for combating drug shortages zbecker Wed, 05/03/2023 - 17:04
MedCity News
MAY 3, 2023
In an interview, Rob Bressler, general manager for Teladoc Health’s virtual primary care solution Primary360, talked about the company’s shift from telehealth for urgent care to whole person care.
Fierce Pharma
MAY 3, 2023
Beating its rivals, GSK nabs world-first approval for adult RSV vaccine Arexvy esagonowsky Wed, 05/03/2023 - 13:07
Medgadget
MAY 3, 2023
Researchers at MIT have developed a printer that can create large numbers of microneedle patch-style vaccines in places where they are needed quickly. Moreover, the printed patches can deliver thermostable mRNA vaccines, whereby the mRNA therapeutic is encapsulated in lipid nanoparticles before printing to enhance its shelf-life at room temperature and avoid the need for cold storage and transport.
Pharma Rep Focus brings together the best content for pharma rep professionals from the widest variety of industry thought leaders.
Legacy MEDSearch
MAY 3, 2023
ORLANDO, Fla., May 3, 2023 – Legacy MEDSearch has been named to the Forbes Best Executive Recruitment Firms and Forbes Best Professional Recruiting Firms out of over 25,000 recruitment and staffing firms in the United States, its fifth consecutive mention since 2019. Forbes Best Recruiting Firms lists are based on votes by industry professionals, who have directly worked with recruiting firms and rankings are earned based on merit.
Fierce Pharma
MAY 3, 2023
AbbVie says Botox rival Revance recruited its employees in bid to steal trade secrets kdunleavy Wed, 05/03/2023 - 12:58
MedCity News
MAY 3, 2023
By forcing providers to coordinate and take responsibility for the overall health of customers, Medicare Advantage can promote the healthcare change we need. It’s a philosophical shift that makes providers think more like insurers and less like businesses that are rewarded for volume, not results.
Fierce Pharma
MAY 3, 2023
As Amgen's revenues slide, so too do sales at its big buyout target Horizon zbecker Wed, 05/03/2023 - 10:51
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
MedCity News
MAY 3, 2023
Israeli medical device developer Magenta Medical recently closed a $55 million financing round. The new funding will be used primarily to help Magenta attain FDA approval for its flagship product — a percutaneous left ventricular assist device called Elevate.
Fierce Pharma
MAY 3, 2023
Optimize Enrollment by Supporting the Full Participant Journey mteefey Wed, 05/03/2023 - 17:06
MedCity News
MAY 3, 2023
Patients treated with Eli Lilly Alzheimer’s disease drug donanemab showed a 35% slowing in decline compared to those given a placebo. Based on the Phase 3 results, Lilly said it would seek FDA approval for the drug by the end of June.
European Pharmaceutical Review
MAY 3, 2023
A market report has shown that the digital biomanufacturing market is anticipated to grow at a compound annual growth rate (CAGR) of 11 percent between 2023-2035, driven largely by digital transformation. Influencing factors identified in the report include higher competition, competitive pricing and inflation rate, technological advancements and evolving regulatory guidelines.
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
MedCity News
MAY 3, 2023
FDA approval of GSK’s respiratory syncytial vaccine Arexvy covers adults age 60 and older—an age group at particular risk of developing severe complications from infection. GSK plans to launch Arexvy in time for the 2023/2024 RSV season.
European Pharmaceutical Review
MAY 3, 2023
The European Commission (EC) has granted approval for Breyanzi (lisocabtagene maraleucel; liso-cel), a CD19-directed chimeric antigen receptor (CAR) T-cell therapy. The CAR T-cell therapy has a 4-1BB costimulatory domain which enhances the expansion and persistence of the CAR T cells. The treatment is indicated for adults with diffuse large B-cell lymphoma (DLBCL), high grade B-cell lymphoma (HGBCL), primary mediastinal large B-cell lymphoma (PMBCL) and follicular lymphoma grade 3B (FL3B) who re
Medgadget
MAY 3, 2023
Researchers at MIT have developed a nanoparticle system that is designed to deliver immunostimulatory drugs to tumors. These drugs are intended to stimulate immune cells in the vicinity of tumors to begin destroying tumor cells, but when delivered systemically they cause unacceptable dose limiting side-effects such as systemic inflammation. These particles are bottle-brush shaped, with the inactive drug being conjugated to the “brush backbone”.
MedCity News
MAY 3, 2023
Federal officials are sounding the alarm on two ransomware groups that are actively targeting the healthcare sector: Cl0p and LockBit. In recent months, the groups have been exploiting three known software vulnerabilities in cyberattacks they have waged against healthcare businesses across the country.
Advertisement
Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.
Medgadget
MAY 3, 2023
AI is increasingly being used in healthcare to reduce clinician workloads and improve patient outcomes. AI-driven technologies are helping to automate mundane tasks, freeing up clinicians to focus on more complex clinical decisions. AI-powered tools can also help identify patterns in medical data that can lead to faster diagnoses and better patient outcomes.
PharmaVoice
MAY 3, 2023
The CEO of a Bay-area startup shares his strategies for growing a team from the ground up.
Pharmaceutical Technology
MAY 3, 2023
Janssen Biotech and the Cellular Biomedicine Group (CBMG) have entered a global collaboration and licence agreement for the development of next-generation chimeric antigen receptor (CAR) T-cell therapies to treat B-cell malignancies. Janssen will gain exclusive rights to develop and commercialise CBMG’s CAR-T assets, C-CAR039 and C-CAR066, excluding the greater China region.
MedCity News
MAY 3, 2023
A new partnership between Horizon and Solera will initially focus on services for musculoskeletal conditions, stress, sleep and resilience, tobacco cessation and weight management. Employers who get their insurance through Horizon will be able to select which conditions its population needs care for and then employees will have access to a selection of health tech vendors for these conditions.
Advertisement
When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.
PharmaTimes
MAY 3, 2023
Recommendation applies across England and Wales and the treatment is available now
Pharma Marketing Network
MAY 3, 2023
The history of women in healthcare is a story of struggle and triumph, of discrimination and determination. Throughout the centuries, women have played a vital role in providing care and comfort to the sick and the injured, and in advancing the field of medicine. Despite facing significant obstacles, they have persevered and made invaluable contributions that have shaped the face of healthcare as we know it today.
Spotio
MAY 3, 2023
High-performing sales teams don’t just happen — they know which activities drive the best outcomes and cut the ones that don’t add value. To build a consistent pipeline that fuels ongoing results, sales reps and sales managers need to know that they’re executing the right activities every single day. With the help of intelligent technology and data-driven insights, reps and managers can understand where and how they can allocate their time, energy, and resources for the highest return.
Pharma Marketing Network
MAY 3, 2023
Introduction Pharmaceutical marketing has come a long way since the traditional approach of detailing and promoting drugs to healthcare professionals. The industry has embraced new technologies and innovative strategies to reach a wider audience and stay ahead of the competition. This article explores some of the latest innovations in pharmaceutical marketing and their impact on the industry. 1.
Advertisement
Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic
Clarivate
MAY 3, 2023
This year the theme of World Intellectual Property Day is “Women and IP: Accelerating innovation and creativity.” Clarivate helps companies accelerate innovation, achieve long-term growth and realize sustainable success. We are happy to continue the global celebration of World IP Day by spotlighting our women IP experts, whose ingenuity and talent pave the way to major breakthroughs.
Pharma Marketing Network
MAY 3, 2023
The pharmaceutical industry has undergone significant changes in recent years, with digital marketing playing an increasingly important role in the way companies communicate with customers and stakeholders. Digital marketing provides a range of innovative tools and techniques for reaching and engaging patients, healthcare providers, and other key decision-makers.
Curzon Consulting
MAY 3, 2023
Principal Consultant Click here to apply Latest news UK’s Leading Management Consultants 2023 2022 MCA Awards Winners We are delighted to welcome a new Partner for Financial Services Sector!
Pharma Marketing Network
MAY 3, 2023
Pharmaceutical marketing is a critical aspect of the industry, as it helps in spreading awareness about the benefits and potential side effects of different drugs. However, pharmaceutical marketing is also regulated by several agencies to ensure that patients are not exposed to false or misleading information. In this article, we will explore the regulatory environment of pharmaceutical marketing and how companies are navigating it to balance patient safety and industry innovation.
Advertisement
As the development pipeline for new drugs continues to grow, biopharmaceutical companies are re-evaluating how to best manage and balance resources across an increasing number of development projects and complex clinical trials. There are two approaches that can be used to speed a drug from development to clinic faster: timeline compression and parallel processing, but only one that considers the benefits of integrating clinical supply into the overall drug development process.
Let's personalize your content